DXF-16553-36026
2 vaccinations
14 coded responses
23 check-ins
14 free-text entries
7 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 860 / AZ
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2021-01-07
Dose 1 — Moderna
-
2021-01-07
Health check-in — day 0, dose 1Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-07
Report sent to call center — day 0, dose 1Be unable to work · Be unable to do your normal daily activitiesno matching call case
-
2021-01-08
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-08
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-09
Survey response — days 1–6 daily, dose 1MedDRA: Dyspnoea — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Difficulty breathingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-10
Survey response — days 1–6 daily, dose 1MedDRA: Dyspnoea — Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Vomiting · Be unable to work, Be unable to do your normal daily activitiesFree text: Difficulty breathingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-10
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-11
Survey response — days 1–6 daily, dose 1MedDRA: Dyspnoea, SARS-CoV-2 test — Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Systemic reaction (other): Difficulty breathing · Healthcare visit (other): Covid testedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-12
Survey response — days 1–6 daily, dose 1MedDRA: Dyspnoea, Rhinorrhoea — Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Difficulty breathing and allergy drainageMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-13
Survey response — days 1–6 daily, dose 1MedDRA: Cough, Dyspnoea — Feeling: Poor · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Difficulty breathing coughingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-14
Survey response — day 7, dose 1MedDRA: Dyspnoea, Hypersensitivity — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Difficulty breathing allergiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-14
Report sent to call center — day 7, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-21
Survey response — day 14, dose 1MedDRA: Cough, Dyspnoea, Migraine — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Difficulty breathing lingering cough migrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-28
-
2021-02-02
Dose 2 — Moderna
-
2021-02-04
Survey response — days 1–6 daily, dose 2MedDRA: Cough, Dyspnoea, Vision blurred — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea, Abdominal pain · Be unable to workFree text: Difficulty breathing cough blurred visionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea, Vertigo, Vision blurred — Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, Nausea, Vomiting · Be unable to workFree text: Difficulty breathing blurry vision vertigoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-06
Survey response — days 1–6 daily, dose 2MedDRA: Cough, Dyspnoea, Vision blurred — Feeling: Fair · Headache, Fatigue or tiredness, Nausea, Vomiting · Be unable to workFree text: Blurry vision difficulty breathing coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-07
Survey response — days 1–6 daily, dose 2MedDRA: Cough, Dyspnoea, Vision blurred — Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to workFree text: Blurry vision difficulty breathing coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-08
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea, Vision blurred — Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to workFree text: Difficulty breathing blurry visionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-09
Survey response — day 7, dose 2MedDRA: Dyspnoea, Vision blurred — Feeling: Fair · Headache, Fatigue or tiredness, Nausea, Vomiting, Diarrhea · Be unable to workFree text: Blurry vision difficulty breathingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-16
- 2021-02-18
-
2021-02-23
Survey response — day 21, dose 2MedDRA: Dyspnoea, Fatigue, Migraine, Pain, Vision blurred — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Harder to breathe. Very tired very quickly. Achy body migraines are still there as well as blurry visionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-02
- 2021-03-11
- 2021-03-16
- 2021-05-08
- 2022-02-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Moderna | |
| 2 | 2021-02-02 | Moderna |
Call center
7 call center cases
7 unsuccessful
1 check-in flagged for a call with no call center case on record
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Difficulty breathing
Systemic reaction (other): Difficulty breathing
Systemic reaction (other): Difficulty breathing and allergy drainage
Systemic reaction (other): Difficulty breathing coughing
Release 2 — day 7, dose 1
Systemic reaction (other): Difficulty breathing allergies
Release 2 — day 14, dose 1
Symptoms: Difficulty breathing lingering cough migraines
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Difficulty breathing cough blurred vision
Systemic reaction (other): Difficulty breathing blurry vision vertigo
Systemic reaction (other): Blurry vision difficulty breathing cough
Systemic reaction (other): Blurry vision difficulty breathing cough
Systemic reaction (other): Difficulty breathing blurry vision
Release 3 — day 7, dose 2
Systemic reaction (other): Blurry vision difficulty breathing
Release 4 — day 21, dose 2
Symptoms: Harder to breathe. Very tired very quickly. Achy body migraines are still there as well as blurry vision
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | SARS-CoV-2 test | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Vision blurred | ✓ | ✓ | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Hypersensitivity | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Vertigo | ✓ | ✓ | ✓ |
| SRO | Vision blurred | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release